

Corner Office Conversation with The New Leaders of Indian Pharma
India’s pharma sector is at a turning point transitioning from a global generics powerhouse to a serious contender in biotech and innovation. In this episode, host Vikas Dandekar is joined by Namita Thapar, Executive Director, Emcure Pharmaceuticals, Aman Mehta, Managing Director, Torrent Pharma, and Sharvil Patel,…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Morning Brief
See all episodes →Similar episodes from other shows
More like The Morning Brief →
How can India’s pharma companies survive under Trump’s uncertainty?

Indian pharma: lofty aims in the midst of chaos

#995 India’s Growth Story and the Cost of Regulatory Cholesterol

Why Indian Pharma struggles with quality control
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.


